CD30 Lateral Flow and Enzyme-Linked Immunosorbent Assays for Detection of BIA-ALCL: A Pilot Study.

Victoria G ZeylHaiying XuImran KhanJason T MachanMark W ClemensHonghua HuAnand DevaCaroline GlicksmanPatricia McGuireWilliam P AdamsDavid SieberMithun SinhaMarshall Edward Kadin

Published in: Cancers (2023)

BIA-ALCL seromas can be distinguished from benign seromas by CD30 ELISA and LFA, but LFA requires less time (<20 min) and can be performed without special equipment by non-specialized personnel, suggesting future point-of-care testing for BIA-ALCL may be feasible.

Keyphrases

palliative care
high throughput
nk cells
current status
loop mediated isothermal amplification
single cell
sensitive detection